Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-024187
Filing Date
2011-03-10
Accepted
2011-03-10 17:00:50
Documents
11
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K w81923e10vk.htm 10-K 1160505
2 EXHIBIT 10.38 w81923exv10w38.htm EX-10.38 35968
3 EXHIBIT 10.39 w81923exv10w39.htm EX-10.39 8454
4 EXHIBIT 10.40 w81923exv10w40.htm EX-10.40 7481
5 EXHIBIT 10.41 w81923exv10w41.htm EX-10.41 14456
6 EX-23.1 w81923exv23w1.htm EX-23.1 1387
7 EXHIBIT 31.1 w81923exv31w1.htm EX-31.1 8249
8 EXHIBIT 31.2 w81923exv31w2.htm EX-31.2 8361
9 EXHIBIT 32.1 w81923exv32w1.htm EX-32.1 4083
10 EXHIBIT 32.2 w81923exv32w2.htm EX-32.2 4199
11 GRAPHIC w81923w8192301.gif GRAPHIC 11999
  Complete submission text file 0000950123-11-024187.txt   1270863
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 11679218
SIC: 2834 Pharmaceutical Preparations